A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Clinical trial NCT02886702 · COMPLETED

Trial details

NCT number: NCT02886702
Sponsor: Fougera Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2016-09-19
Primary completion: 2017-08-02
Enrollment: 855

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.